Enjosim

Series-B
enjosim.com Biotech & Healthcare Shanghai
Total Funding $30.1M
Latest Round $30.1M Series-B
Last Announced Nov 2, 2026
Investors 10 Backers
Decision Makers Profile Active

About Enjosim

Enjosim specializes in the R&D, manufacturing, and sales of self-delivery systems, particularly those for biomacromolecule pharmaceuticals.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Shanghai
Tracked Since Nov 2, 2026

Web & Domain Identity

Official Website enjosim.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $30,080,000 · Series-B

    Backed by CICC

Investors & Backers

10
CICC
Lead
Addor Capital
Co-Stone Venture Capital
HosenCare Brothers
Jiayuan Capital
Maotai Jianxin (Guizhou) Investment Fund
Qiming Venture Partners
Wuxi Yingyue Private Equity Fund Management
Yinman Venture Capital
Zhuhai Science and Technology Industry Group

Funding History

1 Round
Series-B equity · Nov 2, 2026

Round backers: CICC

$30,080,000 donews.com

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts